Hufnagel, Robert
- National Eye Institute (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #785
- Rising Star
- Sustained Excellence
- Top 5% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$4.8M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#785
By linked amount among FY2023 PIs
Earliest Year Loaded
2017
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Hufnagel, Robert as a PI. Multi-PI records show the full award amount for context.
- 1ZIAEY000565-05ZIAContact PIGenomic and epigenomic mechanisms of pediatric ocular disorders$2.5Maward amount
- 1ZIAEY000564-05ZIAContact PIClinical ophthalmic molecular diagnostics and discovery$1.3Maward amount
- 1ZICEY000478-15ZICContact PINational Ophthalmic Disease Genotyping and Phenotyping Network - eyeGENE$999.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Hufnagel, Robert as a PI.
FY2023 award administered by National Eye Institute ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardNational Eye Institute
- 2018$500K Cumulative Funding
- 2018$1M Cumulative Funding
- 2018Entered Top 50% NationallyRanked #4564
- 2018Entered Top 25% NationallyRanked #4564
- 2019$2M Cumulative Funding
- 2021$5M Cumulative Funding
- 2021Entered Top 10% NationallyRanked #1565
- 2022$10M Cumulative Funding
- 2022Entered Top 5% NationallyRanked #908